As of November 2024, Zhejiang CONBA Pharmaceutical has a market cap of $1.44B. This makes Zhejiang CONBA Pharmaceutical the world's 6326th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.77B | -3.56% |
2023 | $1.83B | 6.77% |
2022 | $1.72B | -5.40% |
2021 | $1.81B | 6.16% |
2020 | $1.71B | -23.41% |
2019 | $2.23B | 3.71% |
2018 | $2.15B | -16.12% |
2017 | $2.57B | -3.28% |
2016 | $2.65B | -17.93% |
2015 | $3.23B | 50.51% |
2014 | $2.15B | 11.70% |
2013 | $1.92B | 38.56% |
2012 | $1.39B | 37.91% |
2011 | $1.01B | -30.28% |
2010 | $1.44B | 63.29% |
2009 | $883.92M | 129.58% |
2008 | $385.03M | -56.17% |
2007 | $878.55M | 171.31% |
2006 | $323.82M | 45.73% |
2005 | $222.21M | 0.93% |
2004 | $220.16M | - |